Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating: An Exploratory Study.

NCT06772064 is registered in ClinicalTrials.gov with Xiuli Zuo as lead sponsor.

NCT NCT06772064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06772064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating: An Exploratory Study.
Lead sponsor
Xiuli Zuo
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2025
Completion date
December 1, 2025
Enrollment
115 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sibo